Noticias de Washington DC para el mundo

Inicio
Actualidad
- Latin News
- BW
  - Directorio
DMV
Opinión
Entretenimiento
Deportes
Quiénes Somos
- Archivo

Inicio
Actualidad
- Latin News
- BW
  - Directorio
DMV
Opinión
Entretenimiento
Deportes
Quiénes Somos
- Archivo

Home
Actualidad
Sharapova wins Tokyo final

Sharapova wins Tokyo final

15 años ago394< 1 Min Read

Facebook Twitter LinkedIn Pinterest Stumbleupon Email

Share

Previous PostElogian anuncio de EPA sobre contaminación ambiental

Next PostPayton’s coaching could help Saints

Artículos Relacionados

Supuesto ladrón del bolso de la secretaria de Seguridad Nacional es detenido

Yanko Farias8 horas ago

Foto ilustrativa no relacionada con el caso del robo a Kristi Noem. Foto Google. Redacción ML Noticias Un sospechoso que se cree es la persona que robó el bolso de la secreta...
Más de 200 mil personas despiden al Papa Francisco en la Plaza San Pedro

Yanko Farias21 horas ago

El ataúd a punto de ser colocado en el carro fúnebre camino a la Basílica de Santa María la Mayor. Foto captura de pantalla Redacción ML Noticias Desde muy temprano de este s...
Guatemala: Organizaciones internacionales condenan la criminalización de autoridades indígenas de Guatemala

Yanko Farias1 día ago

Luis Pacheco y Héctor Chaclán esposados. Foto: fger.org Las Américas, 24 de abril de 2025. Las organizaciones firmantes expresamos nuestra profunda alarma y rechazo ante la reci...

Archivos

Archivos

LO ÚLTIMO

Popular

Tendencia

Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease

Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease

8 minutos ago

Supuesto ladrón del bolso de la secretaria de Seguridad Nacional es detenido

Supuesto ladrón del bolso de la secretaria de Seguridad Nacional es detenido

8 horas ago

EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital

EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital

10 horas ago

UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)

UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)

11 horas ago

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

16 horas ago

NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

20 horas ago

Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease

Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease

8 minutos ago

Supuesto ladrón del bolso de la secretaria de Seguridad Nacional es detenido

Supuesto ladrón del bolso de la secretaria de Seguridad Nacional es detenido

8 horas ago

EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital

EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital

10 horas ago

UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)

UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)

11 horas ago

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

16 horas ago

NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

20 horas ago

Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease

Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease

8 minutos ago

Supuesto ladrón del bolso de la secretaria de Seguridad Nacional es detenido

Supuesto ladrón del bolso de la secretaria de Seguridad Nacional es detenido

8 horas ago

EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital

EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital

10 horas ago

UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)

UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)

11 horas ago

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

16 horas ago

NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

NSSC Investors Have Opportunity to Lead Napco Security Technologies, Inc. Securities Fraud Lawsuit with the Schall Law Firm

20 horas ago

Bienvenidos a Metro Latino USA, su portal de noticias.

ÚLTIMA HORA

Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease

27 de abril de 2025
Supuesto ladrón del bolso de la secretaria de Seguridad Nacional es detenido

26 de abril de 2025
EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital

26 de abril de 2025

Categorias

Actualidad (16241)
()
Comunidad (2810)
Entretenimiento (2683)
Deportes (1179)
DMV (1510)
Latin News (403)
Latinoamérica y Mundo (3733)
Maryland (1050)
Opinión (2901)
Virginia (891)

Publicidad

Estamos en

Washington DC.

Website

www.metrolatinousa.com

Escríbenos

[email protected]

© 2024 MetroLatinoUSA.com. Todos los derechos reservados.

¡Síguenos en Facebook!

¡Síguenos en Twitter!

Metro Latino

Metro Latino USA

Metro Latino USA es un sitio informativo digital fundado en 2007 en el área de Washington, DC para crear conciencia ciudadana y sumarse a llamados a la acción con las nuevas plataformas disponibles online.

¡Síguenos!

¡Contáctenos!

[email protected]
www.metrolatinusa.com
Lun-Vier : 8:00 am - 5:00 pm